Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Dr. Reddy's Laboratories ADR is a leading Indian global pharmaceutical company dedicated to developing, manufacturing, and marketing a broad portfolio of high-quality, affordable generics, biopharmaceuticals, and patented medicines. The company is globally committed to advancing patient health through innovative pharmaceutical solutions and research.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Dr. Reddy's Laboratories ADR is scheduled to report its next quarterly earnings on 10/23/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Dr. Reddy's Laboratories ADR last reported quarterly earnings on 7/22/2026 (Q2 2026). Earnings per share (EPS) came in at 5.22 INR.
Across its last 5 earnings reports, Dr. Reddy's Laboratories ADR stock moved by ±4.7% on average the following day. The largest reaction was -9.4% on 07/22/2026; 1 of 5 reactions were positive.
Dr. Reddy's Laboratories ADR has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.